Product How it works Pricing Blog FAQ About Contact
Amneal Pharmaceuticals

Amneal Pharmaceuticals (NASDAQ: AMRX) revenue

Amneal Pharmaceuticals reported revenue of $3,019m for fiscal 2025, 8.0% more than in fiscal 2024 ($2,794m). Since fiscal 2017 its revenue has grown by 192.0%, an average growth of 14.3% a year.

Amneal Pharmaceuticals has grown its revenue for 6 years in a row, and fiscal 2025 is the highest of its 9 fiscal years on record. The biggest drop was in fiscal 2019, −2.2%.

Revenue, in millions of US dollars1,03420171,66320181,62620191,99320202,09420212,21220222,39420232,79420243,0192025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$3,019m+8.0%$394.1m13.1%
2024$2,794m+16.7%$249.3m8.9%
2023$2,394m+8.2%$204.4m8.5%
2022$2,212m+5.7%−$94.9m−4.3%
2021$2,094m+5.1%$152.7m7.3%
2020$1,993m+22.5%$91.2m4.6%
2019$1,626m−2.2%−$248.7m−15.3%
2018$1,663m+60.9%−$19.7m−1.2%
2017$1,034m—$245.1m23.7%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Amneal Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Amneal Pharmaceuticals ranks 89th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Amneal Pharmaceuticals, 8.0%.

RankCompanyRevenueRevenue growth
87thWaters$3,165m7.0%
88thWest Pharmaceutical Services$3,074m6.3%
89thAmneal Pharmaceuticals$3,019m8.0%
90thGlobus Medical$2,939m16.7%
91stNeurocrine Biosciences$2,861m21.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Amneal Pharmaceuticals

How much revenue did Amneal Pharmaceuticals make in fiscal 2025?
Amneal Pharmaceuticals reported revenue of $3,019m for fiscal 2025, compared with $2,794m in fiscal 2024.
How much has the revenue of Amneal Pharmaceuticals grown?
Between fiscal 2017 and fiscal 2025 it went from $1,034m to $3,019m: 192.0% more, an average growth of 14.3% a year.
What was the best year for revenue at Amneal Pharmaceuticals?
Of its last 9 fiscal years, fiscal 2025, with $3,019m.
Where does Amneal Pharmaceuticals rank in its sector by revenue?
It ranks 89th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Amneal Pharmaceuticals come from?
From the annual report (Form 10-K) that Amneal Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Amneal Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Amneal Pharmaceuticals: the Amneal Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.